This activity is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals globally, excluding the UK.

Join leading expert Dr Ralph Audehm for this accredited virtual webinar. Utilizing immersive, narrative-style clinical cases and interactive global case dialogues, this expert-led session equips healthcare providers with the tactical, evidence-based strategies needed to confidently adopt novel anti-obesity medications, optimize precision patient selection at the point of eligibility, and proactively manage treatment side effects through patient-centric monitoring.

Participants will gain actionable strategies for overcoming clinical hesitation, navigating complex therapeutic plateaus during GLP-1RA therapy, and implementing the proactive safety protocols essential for managing adverse events—such as nausea and hypotension—and maximizing the long-term benefits of modern weight management strategies in global obesity care.

Session Highlights

• Early Recognition and Prioritization in Acute Care: Learn how to effectively introduce and navigate weight assessment conversations during brief, routine clinical visits, such as acute consultations for new-onset knee pain or medication refills.
• Initiation of Management at the Point of Eligibility: Explore evidence-based strategies for identifying clinical eligibility and initiating advanced weight management interventions when traditional lifestyle efforts or diet applications fail to produce durable results.
• Managing Therapeutic Plateaus and Non-Response: Gain tactical insights into evaluating treatment efficacy 16 weeks into GLP-1RA therapy, addressing patient discouragement, and clinically determining the next steps when initial weight loss stalls.
• Patient-Centric Monitoring and Side-Effect Mitigation: Master proactive protocols to monitor and manage common GLP-1RA adverse events—such as nausea, vomiting, and lightheadedness from low blood pressure—to prevent premature treatment discontinuation and optimize long-term outcomes.

Who Should Watch

This activity is intended for primary care providers, nurse practitioners, physician assistants/associates, pharmacists, and other healthcare providers who care for patients with obesity.

Faculty

Dr Ralph Audehm is a general practitioner who graduated from Melbourne University in 1984 and has worked for over 25 years in general practice. He is experienced in managing all types of patients. He obtained a Diploma from the Royal Australian College of Obstetricians and Gynaecologists in 1987 and is an Honorary Clinical Associate Professor at the Department of General Practice, University of Melbourne. He has had a long-standing interest in the management of chronic conditions in General Practice especially diabetes and heart disease.

Disclosures

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.

Dr Ralph Audehm, faculty for this educational activity, has the following relevant financial relationships: Advisory Board and Consultant for AstraZeneca, Boehringer Ingelheim, Lilly and NovoNordisk.

The MedAll staff, program planners, and reviewers have no relevant financial relationships with ineligible companies to disclose.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedAll. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Associate Continuing Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 ANCC contact hours.

Pharmacy Continuing Education

Partners designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008073-9999-26-251-L01-P)

Type of Activity: Application

Fee Information

There is no fee for this educational activity.